#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need to counsel patients that cannabis impairs driving ability in ways users consistently fail to recognize, making this a critical patient safety issue similar to alcohol counseling. Understanding this discordance between perceived and actual impairment helps practitioners provide evidence-based guidance on cannabis use and risk mitigation, particularly for patients who operate vehicles or machinery. This knowledge supports informed decision-making during cannabis counseling conversations and allows clinicians to address a documented public health harm that patients may not spontaneously report or acknowledge.
Recent evidence indicates that cannabis users frequently overestimate their driving ability while impaired, yet accident statistics demonstrate objective performance deficits that contradict this subjective perception. This discrepancy between perceived and actual impairment has significant clinical implications, as patients may not recognize functional limitations from cannabis use despite neuromotor and cognitive effects documented in the literature. Clinicians should counsel patients that cannabis impairs driving ability regardless of subjective feelings of competence, similar to alcohol intoxication but potentially less recognized by users. This gap between patient perception and actual impairment mirrors other substance use disorders where insight into functional decline is limited. The editorial challenges the increasingly permissive cultural narrative around cannabis safety and highlights that practitioners must actively educate patients about real-world risks beyond recreational use. Clinicians should explicitly discuss cannabis-related driving impairment during substance use screening and counseling, as patients’ self-assessment cannot be relied upon to determine safety.
“We need to stop treating cannabis as a harmless substance and start having honest conversations with our patients about impaired driving, because the neurocognitive effects are real and measurable, even when users feel completely capable behind the wheel.”
🚗 Cannabis use impairs driving ability, yet users frequently misjudge their own impairment, creating a critical gap between perceived and actual driving safety. This phenomenon is particularly concerning given that unlike alcohol, standardized roadside impairment testing for cannabis remains underdeveloped and variable across jurisdictions, making it difficult for law enforcement to objectively assess cannabis-related driving impairment. Clinicians should recognize that cannabis users’ overconfidence in their driving ability—sometimes termed “cannabis-induced anosognosia” for driving impairment—mirrors similar judgment failures seen with alcohol but may be less recognized by patients themselves. In practice, healthcare providers should routinely counsel cannabis-using patients, particularly regular users, to avoid driving for several hours after use and to be explicit that subjective feelings of competence do not correlate with actual impairment, using this as a teachable moment similar to alcohol counseling.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: